
FTSE on a knifes edge
The FTSE is higher this morning, propped up by a strong rally in medical device maker Smith & Nephew but the news flowis gradually eroding any investor optimism.
Share this:

The FTSE is higher this morning, propped up by a strong rally in medical device maker Smith & Nephew but the news flowis gradually eroding any investor optimism.
First the good news: Smith & Nephew jumped 8% after it reported sales that for the first time surpassed $5 bn. Lloyds Bank also rallied close to 4% despite reporting a 26% drop in annual profits as the decline was within the range that analysts had predicted.
But on a heavier note, the coronavirus provided much more to worry about. The outbreak has now spread into South Korea with the city of Daegu becoming Korea’s Wuhan. If the spread of the virus doesn’t reach its peak until April China’s growth could drop below 5% this year instead of the previously forecast 6%, which would then have repercussions on the growth of technology companies, phone makers, miners, oil producers, airlines and shippers.
This morning Air-France KLM and Maersk were the latest to join the chorus of firms warning about their revenue in the coming quarter because of COVID-19. China is trying to balance out some of the hit to the economy by cutting the lending rate, but it remains to be seen if the cuts are enough to stem the losses.
Brent crude stabilises
Brent crude prices are flat after an overnight rally but the commodity is now trading at its highest level since the outbreak of the virus in China. The ongoing disruption in Libyan supplies and concerns that US sanctions could stifle the outflow of Venezuelan crude into the market are helping Brent crude trade close to $59.20.
The FTSE is higher this morning, propped up by a strong rally in medical device maker Smith & Nephew but the news flowis gradually eroding any investor optimism.
First the good news: Smith & Nephew jumped 8% after it reported sales that for the first time surpassed $5 bn. Lloyds Bank also rallied close to 4% despite reporting a 26% drop in annual profits as the decline was within the range that analysts had predicted.
But on a heavier note, the coronavirus provided much more to worry about. The outbreak has now spread into South Korea with the city of Daegu becoming Korea’s Wuhan. If the spread of the virus doesn’t reach its peak until April China’s growth could drop below 5% this year instead of the previously forecast 6%, which would then have repercussions on the growth of technology companies, phone makers, miners, oil producers, airlines and shippers.
This morning Air-France KLM and Maersk were the latest to join the chorus of firms warning about their revenue in the coming quarter because of COVID-19. China is trying to balance out some of the hit to the economy by cutting the lending rate, but it remains to be seen if the cuts are enough to stem the losses.
Brent crude stabilises
Brent crude prices are flat after an overnight rally but the commodity is now trading at its highest level since the outbreak of the virus in China. The ongoing disruption in Libyan supplies and concerns that US sanctions could stifle the outflow of Venezuelan crude into the market are helping Brent crude trade close to $59.20.
Related tags:
Latest market news
View more newsThe complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.





